EP3854403

Unitary patent

USE OF SUBSTITUTED AMINOPROPIONATE COMPOUNDS IN TREATMENT OF SARS-COV-2 INFECTION

Filed

Oct 16, 2020

Technology

Chemistry · Pharmaceuticals

UPC cases

EPO proceedings

Ownership history

As recorded at the EPO. Transfers made after the opposition period are recorded in national registers and may be missing here.

Academy of Military Medical Sciencessince Jun 25, 2021

Abstract

The present application relates to use of a substituted aminopropionate compound represented by Formula I, a geometric isomer, a pharmaceutically acceptable salt, a solvate and/or a hydrate thereof, and a pharmaceutical composition comprising the compound for the treatment of a disease or an infection caused by a SARS-CoV-2.

Litigation history

Date	Case	Division	Type	Outcome	Parties
Sep 18, 2026	UPC CoA 121/2026	Court of Appeal	Appeal	Locked	Academy of Military Medical Sciences +1

Additional proceedings on this patent

Start 14-day free trialOutcomes, the additional proceedings and the register history.Already a user? Sign in